drugset

drugset / Trial / NCT02259751

Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

NCT02259751 ↗

Phase 1 Completed 26 enrolled Boehringer Ingelheim

RandomizedParallel-groupDouble-blindTreatment

Summary

Study to investigate pharmacodynamic effects and pharmacokinetics of KUC 7483

Timeline

Start: 2004-02
Primary completion: 2005-02
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KUC 7483 CL	Unknown	320 mg	Oral

Indications